il-6 overexpression could be key to covid-19
il-6 overexpression could be key to covid-19
if it is possible to block the signal transduction pathway of il-6, it is expected to become a new method for the treatment of severe covid-19 patients.", "tocilizumab is an il-6 receptor (il-6r) blocker that can effectively block the il-6 signal transduction pathway and thus is likely to become an effective drug for patients with severe covid-19.")